4//SEC Filing
Weil Andrew 4
Accession 0001209191-21-062869
CIK 0000818686other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 7:27 AM ET
Size
5.9 KB
Accession
0001209191-21-062869
Insider Transaction Report
Form 4
Weil Andrew
Chief Accounting Officer
Transactions
- Award
Restricted Share Units
2021-11-02+29,673→ 29,673 total→ Ordinary Shares (29,673 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on November 2, 2021, with 7,418 vesting on each of November 2, 2022, March 5, 2023 and March 5, 2024 and 7,419 vesting on March 5, 2025.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001845020
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 7:27 AM ET
- Size
- 5.9 KB